Home / Top News / Polyol Sweeteners Market Size to Reach USD 4.12 Billion By 2027 | Increasing Adoption in the Food and Beverage Industry and Growing Pharmaceutical Applications will be the Major Factor Driving the Industry Growth, says Reports and Data
Polyol Sweeteners Market Size to Reach USD 4.12 Billion By 2027 | Increasing Adoption in the Food and Beverage Industry and Growing Pharmaceutical Applications will be the Major Factor Driving the Industry Growth, says Reports and Data
Major participants in the sector include Archer Daniels Midland Company (U.S), Cargill (U.S.), E.I. Du Point De Nemours and Company (U.S), Tereos Starch & Sweeteners (France), Südzucker AG (Germany), and Roquette Frères S.A. (France).
Search jobs 13-Jan-2021 Nutrigenomics Testing Market Report, History and Forecast 2021-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pune, Maharashtra, India, January 13 2021 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Nutrigenomics Testing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- The growing prevalence of diabetes and obesity is the major factor driving the growth of Global Nutrigenomics Testing Market.
Nutrigenomics Testing Market is valued at USD 421.3 Million in 2018 and expected to reach USD 919.8 Million by 2025 with CAGR of 11.8% over the forecast period.
Market Analysis of Nutrigenomics Testing-
Nutrigenomics is a field of genetics that helps in determining the nutritional requirements of an individual based on their genetic makeup. It also helps in finding an association between chronic diseases and diet. It is a pa
Global Cell Isolation/Cell Separation Market (2020 to 2025) - Growing Focus on Personalized Medicine Presents Opportunities
ResearchAndMarkets.com s offering.
The global cell isolation market is expected to reach USD 14,995.98 million by 2025 from USD 6894.32 million in 2020, at a CAGR of 16.8% during the forecast period.
Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects and the rising prevalence of diseases such as cancer. With the rising focus on the development of personalized medicine, the number of personalized medications available in the market has steadily increased over the last decade, and this trend is expected to continue in the coming years.